Verona Pharma Plc (VRNA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -18.591 | -30.221 | -24.233 | -53.288 | -48.974 | -28.439 | -30.804 | -19.158 |
Return on Equity (%) | -25.152 | -35.85 | -27.775 | -65.666 | -56.338 | -33.389 | -36.304 | -22.666 |
Return on Invested Capital (%) | -28.138 | -42.273 | -29.523 | -68.575 | -63.206 | -44.975 | -42.057 | -26.998 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -138.118 | -14831.223 | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -138.922 | -15000.218 | N/A |
Book Value Per Share | 0.013 | 0.738 | 0.573 | 0.291 | 0.377 | 0.301 | 0.47 | 0.373 |
Earnings Per Share | -0.002 | -0.195 | -0.189 | -0.303 | -0.133 | -0.114 | -0.14 | -0.081 |
Cash Per Share | 0.015 | 0.299 | 0.188 | 0.218 | 0.385 | 0.303 | 0.466 | 0.407 |
Working Capital Per Share | 0.013 | 0.747 | 0.583 | 0.297 | 0.386 | 0.279 | 0.458 | 0.421 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.082 | N/A | N/A |
EBIT Per Share | -0.002 | -0.24 | -0.229 | -0.372 | -0.133 | -0.114 | -0.14 | -0.081 |
EBITDA Per Share | -0.002 | -0.24 | -0.229 | -0.372 | -0.133 | -0.114 | -0.14 | -0.081 |
Free Cash Flow Per Share | -0.002 | -0.194 | -0.187 | -0.305 | -0.134 | -0.115 | -0.142 | -0.082 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,78B |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 81,83M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales